Nathalie Bernoud-Hubac
Overview
Explore the profile of Nathalie Bernoud-Hubac including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
721
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Lo Van A, Sakayori N, Hachem M, Belkouch M, Picq M, Lagarde M, et al.
Biochimie
. 2016 Aug;
130:163-167.
PMID: 27496085
Docosahexaenoic acid (DHA; 22:6 ω-3) is highly enriched in the brain and is required for proper brain development and function. Its deficiency has been shown to be linked with the...
22.
Hachem M, Geloen A, Lo Van A, Foumaux B, Fenart L, Gosselet F, et al.
Mol Neurobiol
. 2015 Jun;
53(5):3205-3215.
PMID: 26041661
Docosahexaenoic acid (DHA) is the main essential omega-3 fatty acid in brain tissues required for normal brain development and function. An alteration of brain DHA in neurodegenerative diseases such as...
23.
Salvatore G, Bernoud-Hubac N, Bissay N, Debard C, Daira P, Meugnier E, et al.
J Lipid Res
. 2015 Apr;
56(6):1110-22.
PMID: 25833686
Interleukin 17A (IL-17A) is a proinflammatory cytokine involved in the pathogenesis of chronic inflammatory diseases. In the field of immunometabolism, we have studied the impact of IL-17A on the lipid...
24.
Vial G, Chauvin M, Bendridi N, Durand A, Meugnier E, Madec A, et al.
Diabetes
. 2015 Jan;
64(6):2254-64.
PMID: 25552598
Imeglimin is the first in a new class of oral glucose-lowering agents currently in phase 2b development. Although imeglimin improves insulin sensitivity in humans, the molecular mechanisms are unknown. This...
25.
Guichardant M, Calzada C, Bernoud-Hubac N, Lagarde M, Vericel E
Biochim Biophys Acta
. 2014 Sep;
1851(4):485-95.
PMID: 25263947
Numerous epidemiological studies and clinical trials have reported the health benefits of omega-3 polyunsaturated fatty acids (PUFA), including a lower risk of coronary heart diseases. This review mainly focuses on...
26.
Lagarde M, Bernoud-Hubac N, Calzada C, Vericel E, Guichardant M
Mol Nutr Food Res
. 2013 Jul;
57(8):1347-58.
PMID: 23818385
Polyunsaturated fatty acids in mammals may be oxygenated into a myriad of bioactive products through di- and monooxygenases, products that are rapidly degraded to control their action. To evaluate the...
27.
Lefils-Lacourtablaise J, Socorro M, Geloen A, Daira P, Debard C, Loizon E, et al.
PLoS One
. 2013 Jun;
8(5):e63997.
PMID: 23734181
The intake of ω-3 polyunsaturated fatty acids (PUFAs), which are abundant in marine fish meat and oil, has been shown to exert many beneficial effects. The mechanisms behind those effects...
28.
Lagarde M, Bernoud-Hubac N, Guichardant M
Mol Membr Biol
. 2012 May;
29(7):222-8.
PMID: 22594701
This short review takes into consideration the status of lipidomics as issued from almost a decade of development. Because of the huge number of molecular species analyzed, there is a...
29.
Laugerette F, Furet J, Debard C, Daira P, Loizon E, Geloen A, et al.
Am J Physiol Endocrinol Metab
. 2011 Nov;
302(3):E374-86.
PMID: 22094473
Low-grade inflammation observed in obesity is a risk factor for cardiovascular disease. Recent studies revealed that this would be linked to gut-derived endotoxemia during fat digestion in high-fat diets, but...
30.
Davies S, Bodine C, Matafonova E, Pantazides B, Bernoud-Hubac N, Harrison F, et al.
J Alzheimers Dis
. 2011 Jun;
27(1):49-59.
PMID: 21709376
Both inflammation and oxidative injury are features of Alzheimer's disease (AD), but the contribution of these intertwined phenomena to the loss of working memory in this disease is unclear. We...